Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
De mogelijkheden van alfa-synucleïne SAA’s bij Parkinson
mei 2023 | Bewegingsstoornissen